Skip to main content
. 2007 Mar 7;109(12):5399–5406. doi: 10.1182/blood-2006-12-062943

Table 2.

Daclizumab inhibits CD40L expression independently of cell division in memory CD4+ T cells

CD45RA
Cell divisions at 48 hrs
Total
% Divided 2 1 0
Control 7 (4) 54 (4) 40 (6) 100%
Daclizumab 0 37 (6) 64 (6) 100%
% CD40L+ 2 1 0 Total
Control 5 (3) 38 (6) 20 (2) 63%
Daclizumab 0 13 (5) 14 (3) 27%

Results shown are mean (± SE) of 4 donors.